Skip to Content

Join the 'Bladder Cancer' group to help and get support from people like you.

Bladder Cancer News

Related terms: Cancer, Bladder

Report: Industry Hid Decades-Old Study Showing Sugar's Unhealthy Effects

Posted 20 days ago by Drugs.com

TUESDAY, Nov. 21, 2017 – Big Sugar seems to have copied the Big Tobacco playbook, a new report contends. More than four decades ago, a study in rats funded by the sugar industry found evidence linking the sweetener to heart disease and bladder cancer, the paper trail investigation reports. The results of that study were never made public. Instead, the sugar industry pulled the plug on the study and buried the evidence, said senior researcher Stanton Glantz. He is a professor of medicine and director of the University of California, San Francisco (UCSF) Center for Tobacco Control Research and Education. Glantz likened this to suppressed Big Tobacco internal research linking smoking with heart disease and cancer. "This was an experiment that produced evidence that contradicted the scientific position of the sugar industry," Glantz said. "It certainly would have contributed to increasing ... Read more

Related support groups: Obesity, Bladder Cancer, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction

Patients' Gut Bugs May Play Role in Cancer Care

Posted 3 Nov 2017 by Drugs.com

THURSDAY, Nov. 2, 2017 – The type of bacteria that cancer patients harbor in the gut might affect their odds of responding to certain treatments, two early studies hint. The research, in humans and mice, adds to evidence that gut bacteria play a key role in the immune system. But experts stressed it's too soon to make recommendations to cancer patients – including whether they should take "probiotic" supplements. Both studies looked at whether there's a link between patients' gut bacteria and their responses to newer cancer drugs called PD-1 inhibitors. The drugs, which include Keytruda (pembrolizumab) and Opdivo (nivolumab), work by freeing up the immune system to attack cancer cells. The drugs are approved for several cancers, including advanced cases of melanoma, lung, bladder and stomach cancers. In one study, researchers focused on 112 patients with advanced melanoma, the ... Read more

Related support groups: Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Melanoma, Opdivo, Bladder Cancer, Keytruda, Nivolumab, Pembrolizumab, Gastrinoma

Tighter Rules on Arsenic in Water Saved Lives: Study

Posted 23 Oct 2017 by Drugs.com

MONDAY, Oct. 23, 2017 – U.S. government limits on arsenic in drinking water has likely averted hundreds of cases of lung and bladder cancer annually, a new study suggests. After the Environmental Protection Agency introduced tighter limits on arsenic in public drinking water in 2006, there was a 17 percent decrease in levels of arsenic in the urine of people served by public water systems that complied with the rule, the researchers found. Not only that, but there were an estimated 200 fewer cases of lung and bladder cancer a year after the tougher rules were put in place. Levels of arsenic in the urine of people who used private wells did not change, according to the study published Oct. 23 in The Lancet Public Health journal. Arsenic is a carcinogen that naturally occurs in drinking water across the United States. The study findings highlight the important role that government ... Read more

Related support groups: Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Skin Cancer, Bladder Cancer, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction, Trisenox, Arsenic Trioxide, Bronchogenic Carcinoma

Treatment Costs Can Be Another Blow to Cancer Patients

Posted 27 Jul 2017 by Drugs.com

THURSDAY, July 27, 2017 – The emotional and physical costs of cancer can be staggering. But the financial side of cancer is also a great burden, with many patients in the United States struggling to pay for treatment, new research reveals. "The current health law has greatly improved access to meaningful health coverage for cancer patients, survivors and all those with chronic diseases," Chris Hansen, president of the American Cancer Society Cancer Action Network, said in a network news release. "Yet costs remain a challenge for those facing cancer. Our country and our lawmakers should come together to find bipartisan solutions that begin to address patient costs without sacrificing the quality of coverage," he urged. Researchers surveyed financial navigators at 11 hospitals in nine states. Financial navigators – typically trained social workers or nurses – help cancer patients ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Breast Cancer, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Lung Cancer, Gleevec, Colorectal Cancer, Non-Small Cell Lung Cancer, Brain Tumor, Anastrozole, Letrozole, Skin Cancer, Tarceva

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 19 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In the new policy statement, ASCO also says it supports creation of a panel of "stakeholders" in health care to determine the effectiveness of its proposals. Such a group might also outline a uniform approach for assessing the value of drugs. "In what, undoubtedly, is one of the most difficult times in their lives, individuals with cancer should be focused on getting the best care possible, not worrying about financial strain on their families," said Dr. Clifford Hudis. He's CEO of ASCO, a leading ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Fluorouracil, Lupron Depot, Femara, Lung Cancer, Gleevec, Colorectal Cancer, Brain Tumor, Anastrozole, Votrient, Letrozole

Could Certain Hair Dyes, Relaxers Raise Breast Cancer Risk?

Posted 20 Jun 2017 by Drugs.com

TUESDAY, June 20, 2017 – The safety of hair products has been debated for years. Now, new research suggests that black women who use dark hair dyes face a higher risk of breast cancer, while chemical relaxers and straighteners boost the odds in white women. The findings stem from a study of more than 4,000 women. Use of dark brown or black hair dyes by black women was tied to a 51 percent greater risk of breast cancer. And whites who used hair relaxers had 74 percent higher odds. But while the study found a possible link between the hair products and breast cancer risk, it did not prove a connection. "Our findings do not suggest that simply using hair dyes, relaxers or both will cause a woman to get breast cancer," cautioned study lead author Adana Llanos. "The reality is that we regularly encounter a variety of harmful exposures, which we have no control over," said Llanos, an ... Read more

Related support groups: Breast Cancer, Poisoning, Bladder Cancer, Breast Cancer, Prevention

'Couch Potatoes' May Face Higher Risk of Kidney, Bladder Cancers

Posted 15 Jun 2017 by Drugs.com

THURSDAY, June 15, 2017 – Add greater risk of kidney and bladder cancer to the long list of why a lifetime of sitting on the sofa isn't good for your health, a new study suggests. Specifically, lifetime recreational inactivity was associated with a 73 percent increased risk of bladder cancer and a 77 percent increased risk of kidney cancer. The findings add to growing evidence that inactivity may be a significant risk factor for cancer, the researchers said. "We hope that findings like ours will motivate inactive people to engage in some form of physical activity," said study senior author Kirsten Moysich. She is a professor of oncology at Roswell Park Cancer Institute in Buffalo, N.Y. "You don't have to run marathons to reduce your cancer risk, but you have to do something – even small adjustments like taking the stairs instead of the elevator, walking around the block a couple of ... Read more

Related support groups: Obesity, Cancer, Weight Loss, Renal Failure, Renal Cell Carcinoma, Chronic Kidney Disease, Bladder Cancer, Solid Tumors, Urothelial Carcinoma

E-Cigarettes Linked to Bladder Cancer Risk

Posted 15 May 2017 by Drugs.com

MONDAY, May 15, 2017 – Although many people think "vaping" is safer than smoking, research suggests that both e-cigarettes and traditional cigarettes are tied to an increased risk for bladder cancer. "We've known traditional smoking raises bladder cancer risk, and given the surge in popularity of e-cigarettes, it's imperative we uncover any potential links" between e-cigarettes and bladder cancer, Dr. Sam Chang said in an American Urological Association news release. Chang is a professor of urologic surgery at Vanderbilt-Ingram Cancer Center in Nashville. Most inhaled nicotine is excreted in the urine. For the study, the researchers compared the urine of people who use e-cigarettes with that of nonsmokers. The investigators looked for five chemicals known to cause bladder cancer and may be found in e-cigarette liquid. Ninety-two percent of e-cigarette users tested positive for two of ... Read more

Related support groups: Smoking, Smoking Cessation, Nicotine, Nicorette, Nicoderm CQ, Bladder Cancer, Nicotrol Inhaler, Commit, Habitrol, Nicorelief, Nicorette DS, Urothelial Carcinoma, Nicotrol NS, ProStep, Nicotrol TD

AstraZeneca’s Imfinzi (durvalumab) Receives FDA Accelerated Approval for Previously Treated Patients with Advanced Bladder Cancer

Posted 1 May 2017 by Drugs.com

May 1, 2017 – AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has granted accelerated approval to Imfinzi (durvalumab). Imfinzi is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma (mUC) who have disease progression during or following platinum-containing chemotherapy, or whose disease has progressed within 12 months of receiving platinum-containing chemotherapy before (neoadjuvant) or after (adjuvant) surgery. Imfinzi is approved under the FDA’s accelerated approval pathway, based on tumor response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials. Pascal Soriot, Chief Executive Officer of AstraZeneca, said: “We are excited to off ... Read more

Related support groups: Bladder Cancer, Imfinzi, Urothelial Carcinoma, Durvalumab

Survival Continues to Improve for Most Cancers

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – Overall cancer death rates in the United States continue to fall, but racial gaps persist, a new report says. Death rates fell between 2010 and 2014 for 11 of the 16 most common cancers in men and for 13 of the most common types in women, including lung, colon, prostate and breast cancers. However, death rates rose for cancers of the liver, pancreas and brain in men and for the liver and uterus in women. And improvements in cancer survival weren't equal for all Americans. "While this report found that five-year survival for most types of cancer improved among both blacks and whites over the past several decades, racial disparities for many common cancers have persisted, and they may have increased for prostate cancer and female breast cancer," said Dr. Lynne Penberthy. She's associate director of the U.S. National Cancer Institute's Surveillance Research ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Skin Cancer, Melanoma, Pancreatic Cancer, Ovarian Cancer, Endometrial Cancer, Osteosarcoma, Small Cell Lung Cancer, Breast Cancer - Adjuvant, Bladder Cancer, Cervical Cancer, Breast Cancer, Prevention

Cancer Survivors Gain From Web-Based Health Care

Posted 10 Feb 2017 by Drugs.com

FRIDAY, Feb. 10, 2017 – Online- and phone-based health care offers a number of benefits for cancer survivors, British researchers report. The new study looked at previous research on cancer survivors' experiences with online and phone health contacts – what the researchers call telehealth. The review found that patients liked the flexibility and convenience of this method of staying in touch with their care providers because they could do so in a familiar, comfortable setting and with minimum disruption to their lives. The perceived anonymity of telehealth reduced patients' sense of vulnerability and some said they were more comfortable raising concerns in this setting than in face-to-face appointments. Negative aspects of telehealth mentioned by patients included not being able to meet their health care providers in person, while other patients said they couldn't use the service due ... Read more

Related support groups: Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Skin Cancer, Ovarian Cancer, Small Cell Lung Cancer, Bladder Cancer, Cervical Cancer, Breast Cancer, Prevention, Head and Neck Cancer, Stomach Cancer, Breast Cancer - Palliative, Testicular Cancer, Wilms' Tumor, Zollinger-Ellison Syndrome, Solid Tumors

Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) in Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma

Posted 10 Feb 2017 by Drugs.com

PRINCETON, N.J.--(BUSINESS WIRE)-- February 2, 2017 – Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has approved Opdivo injection, for intravenous use for the treatment of patients with locally advanced or metastatic urothelial carcinoma (mUC) who have disease progression during or following platinum-containing chemotherapy or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy. This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.1 The recommended dose for mUC is 240 mg administered as an intravenous infusion over 60 minutes every two weeks until disease progression or ... Read more

Related support groups: Opdivo, Bladder Cancer, Nivolumab, Urothelial Carcinoma

Cancer Advances Demand Continual Funding, Specialists Say

Posted 29 Nov 2016 by Drugs.com

TUESDAY, Nov. 29, 2016 – Sufficient and sustained funding for cancer research should be a global priority, European and American cancer organizations said at the start of an international oncology conference in Germany on Tuesday. Significant progress has been made in the understanding of how cancer develops. But, consistent research funding is needed to take advantage of these advances to improve cancer survival rates, according to specialists from two of the cancer organizations sponsoring the Munich meeting. "There has never been a more exciting time in cancer research," said Dr. Denis Lacombe, director general of the European Organisation for Research and Treatment of Cancer (EORTC). "With the surge in molecular biology developments and a growing consideration for cost-benefit balance from a public health perspective, there is an increasing need to invest in cancer research and ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Bladder Cancer, Cervical Cancer, Head and Neck Cancer

Low Vitamin D Levels May Raise Bladder Cancer Risk: Study

Posted 8 Nov 2016 by Drugs.com

TUESDAY, Nov. 8, 2016 – Low vitamin D levels may increase the risk of bladder cancer, researchers report. Five of seven studies the researchers reviewed linked low vitamin D levels with an higher risk of bladder cancer. In experiments with the cells that line the bladder, the researchers found that the cells activate and respond to vitamin D. This, in turn, can stimulate an immune response, the study authors said. The finding is important because the immune system may help prevent cancer by identifying and destroying abnormal cells before they develop into cancer, according to lead author Rosemary Bland, an honorary associate professor at the University of Warwick in England. "More clinical studies are required to test this association, but our work suggests that low levels of vitamin D in the blood may prevent the cells within the bladder from stimulating an adequate response to ... Read more

Related support groups: Cancer, Vitamin D Deficiency, Bladder Cancer, Caltrate 600 with D, Calcium/Vitamin D, Citracal Petites, Citracal + D, Calcet, Oyster Shell Calcium, Calcarb with D, Calcium 600 D, Citracal Creamy Bites, Osteocit D Plus, Dical Captabs, Oysco D, Citracal Maximum, Dicalphos plus D, Caltro with Vitamin D, Oyst-Cal-D, UPCal D

Cancer Patients in Poorer Countries Often Go Without Radiation

Posted 2 Oct 2016 by Drugs.com

THURSDAY, Sept. 29, 2016 – Many cancer patients in low- and middle-income nations who would benefit from radiation treatment don't receive it, a new study finds. "In Ghana and the Philippines, for example, about eight in 10 cancer patients who need radiation therapy will not receive needed treatment," said study co-author Dr. Elena Fidarova, a researcher at the International Atomic Energy Agency in Vienna, Austria. She and her colleagues analyzed data from nine nations: Costa Rica, Ghana, Malaysia, the Philippines, Romania, Serbia, Slovenia, Tunisia and Uruguay. Overall, about five out of 10 cancer patients in these countries require radiation therapy to shrink tumors and kill cancer cells. But up to half of them do not have access to it, the researchers found. In individual nations, the rates of patients who can benefit from radiation therapy but do not receive it ranged from 18 to 82 ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Brain Tumor, Bladder Cancer, History - Radiation Therapy

Page 1 2 3 4 5 Next

Ask a Question

Further Information

Related Condition Support Groups

Urothelial Carcinoma, Cancer

Related Drug Support Groups

methotrexate, cisplatin, cyclophosphamide, doxorubicin, Tecentriq, mitomycin, Adriamycin, Platinol, thiotepa, view more... atezolizumab, Mutamycin, Platinol-AQ, Adriamycin RDF, Thioplex, Adriamycin PFS, Tepadina